About this trial
The goal of this clinical trial is to evaluate the feasibility, acceptability, and preliminary efficacy of mindfulness-based interventions (MBI) as a vaping cessation intervention in young adults aged 18-29 who vape nicotine at least 25 days per month and are interested in cutting down or quitting. The main questions it aims to answer are:
* Can mindfulness practice reduce nicotine cravings in young adults? * Is mindfulness practice an acceptable and feasible intervention for vaping cessation in this population?
Researchers will compare participants in the mindfulness intervention group to a control group that watches a video with calming music and images to see if mindfulness practice has a greater effect on reducing nicotine cravings.
Participants will:
* Complete a baseline survey and craving cue reactivity assessment. * Engage in a 10-minute guided mindfulness meditation (intervention group) or view calming music and images (control group). * Rate their cravings and the acceptability, appropriateness, and feasibility of the intervention after the session.
Eligibility criteria
Qualifiers
Young adults aged 18-29 years old
Residing in the United States
Able to read and speak English
Vape nicotine at least 25 days/month,
Disqualifiers
Using any nicotine-containing products other than e-cigarettes
A current or past Diagnostic and Statistical Manual of Mental Disorders (DSM-5) psychiatric diagnosis of severe mental illness
A current DSM diagnosis of substance use disorders other than tobacco use disorder
Involved in regular mindful practice
Trial design
Treatments tested in this trial
- Guided mindfulness meditation
- Scenery video
Treatment groups
Locations
Sponsors and collaborators
Tulane University
Lead sponsor
Michigan State University
Collaborator